Updated findings from a phase 3 study show significantly better 8-year progression-free survival with external beam radiation therapy added to androgen deprivation therapy (ADT) vs ADT alone.
Implementation of the ERAS protocol has a dramatic effect on outcomes for patients undergoing prostate or renal cancer surgery.
A clinical trial sought to determine if a web-based patient decision making aid could improve satisfaction with care, reduce regrets, and improve alignment of risk category with treatment choice in men with localized prostate cancer.
But during extended exposure periods of at least five years, low-dose aspirin may cut mortality.
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.